Siemens Healthineers AG
XETRA:SHL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.93
57.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Siemens Healthineers AG
Siemens Healthineers AG
Cost of Revenue
Siemens Healthineers AG
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Cost of Revenue
-€13.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Cost of Revenue
-€927.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-8%
|
|
|
Stratec SE
XETRA:SBS
|
Cost of Revenue
-€182.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Cost of Revenue
-€216.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-13%
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Cost of Revenue
-€1.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Sartorius AG
XETRA:SRT
|
Cost of Revenue
-€1.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-16%
|
|
Siemens Healthineers AG
Glance View
Nestled at the intersection of innovation and healthcare, Siemens Healthineers AG carries forth the legacy of its parent conglomerate, Siemens, into the realm of medical technology. Headquartered in Erlangen, Germany, Siemens Healthineers has made it its mission to transform care delivery and shape a new age of healthcare. The company leverages its extensive engineering expertise and robust R&D capabilities to design a broad spectrum of healthcare solutions that range from imaging systems and in-vitro diagnostics to advanced therapy solutions and services. Their cutting-edge imaging portfolio includes MRI, CT, and X-ray systems, which aid physicians in making precise diagnoses. By harnessing data analytics and AI, they offer tools that go beyond traditional diagnostics, enabling more personalized and efficient patient care. The crux of Siemens Healthineers' business model lies not only in selling sophisticated medical equipment but also in a substantial service component. Maintenance contracts, performance upgrades, and consulting services ensure a steady revenue stream and deepen client relationships. The company also invests in digital health services, driven by a vision to empower healthcare providers with swift, data-infused insights. Through partnerships with healthcare institutions worldwide, Siemens Healthineers develops tailored solutions that enhance operational efficiency, patient experience, and clinical outcomes. These collaborations help expand their market footprint and solidify their position as an indispensable partner in the ever-evolving healthcare landscape. In essence, Siemens Healthineers helps healthcare providers improve patient outcomes while optimizing their operational workflows, thus deriving mutual growth and success.
See Also
What is Siemens Healthineers AG's Cost of Revenue?
Cost of Revenue
-13.7B
EUR
Based on the financial report for Jun 30, 2024, Siemens Healthineers AG's Cost of Revenue amounts to -13.7B EUR.
What is Siemens Healthineers AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%
Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Siemens Healthineers AG have been -10% over the past three years , -10% over the past five years .
You don't have any saved screeners yet
